CHMP Adopts Positive Opinion for Aflibercept, Pegfilgrastim Biosimilars:  On January 30, 2025, the European Medicines Agency (EMA) Committee ...
A comprehensive strategy that combines pharmacological advances, vector control, public outreach to raise awareness and ...